Typhaine Martin
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Hippo pathway signaling and YAP/TAZ, Cancer-related Molecular Pathways, Plant Surface Properties and Treatments, Cell death mechanisms and regulation, Microtubule and mitosis dynamics
Most-Cited Works
- → Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening(2017)693 cited
- → Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers(2024)114 cited
- → The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity(2013)94 cited
- → Effect of the acylation of TEAD4 on its interaction with co‐activators YAP and TAZ(2017)69 cited
- → Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD(2017)56 cited
- → Identification of FAM181A and FAM181B as new interactors with the TEAD transcription factors(2019)35 cited
- → Cancer lineage-specific regulation of YAP responsive elements revealed through large-scale functional epigenomic screens(2023)19 cited
- → Author Correction: Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers(2024)7 cited
- → Author response: Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD(2017)
- → A new perspective on the evolution of the interaction between the Vg/VGLL1-3 proteins and the TEAD transcription factors(2020)